A Lightweight Hybrid Dilated Ghost Model-Based Approach for the Prognosis of Breast Cancer.

Most approaches use interactive priors to find tumours and then segment them based on tumour-centric candidates. A fully convolutional network is demonstrated for end-to-end breast tumour segmentation. When confronted with such a variety of options, to enhance tumour detection in digital mammograms, one uses multiscale picture information.

Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer.

Background: Data from randomized trials in postmenopausal women receiving endocrine therapy for breast cancer would suggest that the incidence of significant urogenital symptoms is around 40%. As there are inherent reporting biases associated with clinical trials, we sought to assess the prevalence, severity, and effect of urogenital side effects of endocrine therapy in the non-trial setting.

Patients And Methods: A cross-sectional survey study was undertaken and questionnaires used to assess vulvovaginal and urinary tract symptoms in a group of postmenopausal women receiving endocrine therapy for breast cancer.

Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte counts.

Seventy-eight infectious episodes in 75 cancer patients with adequate granulocyte counts were treated with cefotaxime. Sixty-six episodes were evaluable. The overall cure rate was 77% (51/66).